2011 Cannabinoids Clinical Trials THC 
Project CBD
MARCH 21, 2023
While animal studies have revealed that cannabinoid receptors likely have a role in modulating auditory signaling, there is no compelling data either from animal or human studies for the use of cannabinoids to alleviate tinnitus.” There could be a role for cannabinoids in the management of tinnitus through their anticonvulsant effects.
Project CBD
FEBRUARY 27, 2023
Researchers have been investigating the use of cannabis to treat fibromyalgia’s constellation of symptoms for decades, with early clinical trials in the 2000s 1-4 suggesting a possible benefit of both pure THC and flower in managing the disease. It’s not a new idea. That seemed to make all the difference.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
FEBRUARY 1, 2023
Even if a cannabinoid has shown promise on one cancer line, that doesn’t mean it will work for all cancers – even if it’s within the same organ system. Advocate for the rescheduling of cannabis to improve access to cannabis for research purposes, and scientific funding for novel cannabinoid-based cancer therapies.
The Cannigma
JUNE 23, 2022
While CBG (cannabigerol) has been hailed ‘the mother of all cannabinoids,’ it’s time to reveal the true heir to the throne – cannabigerolic acid, or CBGA. This cannabinoid has only recently been studied, and future studies will certainly divulge its exact importance. Unlike THC, neither CBG nor CBGA are intoxicating.
Green Relief
MAY 13, 2018
government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”. CBD produces no intoxicating effects, no THC -like high, and its use does not lead to tolerance. Cannabinoids to the rescue.
The Cannigma
MAY 19, 2021
Medical : Illegal Recreational : Illegal *CBD products are legal in Japan, as long as they contain no THC whatsoever and are not made from cannabis flower. In 2019, Japan approved clinical trials for Epidiolox — a cannabis derived medicine used to treat severe forms of childhood epilepsy such as Dravet and Lennox-Gastaut syndromes.
Greencamp
FEBRUARY 17, 2019
We produce endocannabinoids—internal cannabinoid-like compounds, that bind to these cellular endocannabinoid receptors. Cannabinoids: A Guide to 13 Bioactive Compounds from Weed. 6 ) This is promising to those looking to treat some of the persistent IBS symptoms without experiencing the psychotropic effects of THC.
Expert insights. Personalized for you.
144 
Let's personalize your content